Literature DB >> 8224123

Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban community.

S Humerfelt1, A Gulsvik, R Skjaerven, S Nilssen, G Kvåle, O Sulheim, E Ramm, E Eilertsen, S B Humerfelt.   

Abstract

The purpose of this survey was to evaluate the effects of smoking and occupational exposures on the decline in forced expiratory volume in one second (FEV1), and the presence of airflow limitation (FEV1 x100/forced vital capacity (FVC) being < 65) at follow-up. A random sample of 1,933 men aged 22-54 years in Bergen, Norway, were invited into the survey. Smoking habits and measurements of FEV1 were recorded at the initial survey in 1965-1970 (n = 1,591) and at follow-up in 1988-1990 (n = 951). Past or present self-reported occupational exposures to eleven airborne agents (dusts, gases, vapours and fumes) and measurements of FVC were recorded at follow-up only. The decline in FEV1 was associated (p < 0.001) with age, body height and smoking. Smoking cessation reduced the decline to the level of lifetime nonsmokers. Accelerated decline in FEV1 was observed in subjects exposed to sulphur dioxide gas and to metal fumes. The adjusted decline in FEV1 increased progressively in subjects exposed to increasing numbers of occupational agents (test for trend: p < 0.01). Airflow limitation was observed in 9.5% at follow-up, and increased with age and cigarette consumption. In this community follow-up survey in men, smoking and occupational exposures to sulphur dioxide gas, metal fumes and the numbers of specific agents were found to be important predictors for accelerated decline in FEV1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224123

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Smoking and ulcer perforation.

Authors:  C Svanes; J A Søreide; A Skarstein; B T Fevang; P Bakke; S E Vollset; K Svanes; O Søoreide
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

Review 2.  Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease.

Authors:  Julio D Antuni; Peter J Barnes
Journal:  Chronic Obstr Pulm Dis       Date:  2016-06-28

3.  Predictors of spirometric test failure: a comparison of the 1983 and 1993 acceptability criteria from the European Community for Coal and Steel.

Authors:  S Humerfelt; G E Eide; G Kvåle; A Gulsvik
Journal:  Occup Environ Med       Date:  1995-08       Impact factor: 4.402

4.  Vapor, dust, and smoke exposure in relation to adult-onset asthma and chronic respiratory symptoms: the Singapore Chinese Health Study.

Authors:  Tricia D LeVan; Woon-Puay Koh; Hin-Peng Lee; David Koh; Mimi C Yu; Stephanie J London
Journal:  Am J Epidemiol       Date:  2006-05-17       Impact factor: 4.897

Review 5.  Chlorine: state of the art.

Authors:  Richard B Evans
Journal:  Lung       Date:  2005 May-Jun       Impact factor: 2.584

6.  Association of years of occupational quartz exposure with spirometric airflow limitation in Norwegian men aged 30-46 years.

Authors:  S Humerfelt; G E Eide; A Gulsvik
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

7.  Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease.

Authors:  Philip Harber; Donald P Tashkin; Michael Simmons; Lori Crawford; Eva Hnizdo; John Connett
Journal:  Am J Respir Crit Care Med       Date:  2007-07-12       Impact factor: 21.405

8.  Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach.

Authors:  Xaver Baur; Prudence Bakehe; Henning Vellguth
Journal:  J Occup Med Toxicol       Date:  2012-09-26       Impact factor: 2.646

Review 9.  Systematic review of the evidence relating FEV1 decline to giving up smoking.

Authors:  Peter N Lee; John S Fry
Journal:  BMC Med       Date:  2010-12-14       Impact factor: 8.775

Review 10.  Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease.

Authors:  R Walter; D J Gottlieb; G T O'Connor
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.